PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2018. Start Trial.
Date Value
November 19, 2026 0.2535
November 18, 2026 0.2756
November 17, 2026 0.2878
November 16, 2026 0.2866
November 13, 2026 0.2976
November 12, 2026 0.305
November 11, 2026 0.3197
November 10, 2026 0.3246
November 09, 2026 0.3491
November 06, 2026 0.3577
November 05, 2026 0.3442
November 04, 2026 0.3626
November 03, 2026 0.3246
November 02, 2026 0.3123
October 30, 2026 0.3099
October 29, 2026 0.3234
October 28, 2026 0.3295
October 27, 2026 0.3393
October 26, 2026 0.3332
October 23, 2026 0.3442
October 22, 2026 0.3589
October 21, 2026 0.3577
October 20, 2026 0.3711
October 19, 2026 0.3711
October 16, 2026 0.3724
Date Value
October 15, 2026 0.3932
October 14, 2026 0.3846
October 13, 2026 0.4005
October 12, 2026 0.4116
October 09, 2026 0.4336
October 08, 2026 0.4397
October 07, 2026 0.455
October 06, 2026 0.463
October 05, 2026 0.4557
October 02, 2026 0.4422
October 01, 2026 0.4373
September 30, 2026 0.4593
September 29, 2026 0.4838
September 28, 2026 0.4924
September 25, 2026 0.5059
September 24, 2026 0.4985
September 23, 2026 0.5034
September 22, 2026 0.5181
September 21, 2026 0.4997
September 18, 2026 0.4887
September 17, 2026 0.4826
September 16, 2026 0.4814
September 15, 2026 0.4887
September 14, 2026 0.5071
September 11, 2026 0.4924

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
cbdMD, Inc. 0.1631
SNDL, Inc. 0.4587
CannaPharmaRx, Inc. 1.389
Cosmos Health, Inc. 0.0820
Lexaria Bioscience Corp. 32.23

PS Ratio Related Metrics

Price to Book Value 0.1670
Price 1.885
Earnings Yield -74.04%
Market Cap 271.08M